Evidence map›Paper›PMID 23313952›Full record

ArticleNature genetics2013

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.

Dan R Robinson, Yi-Mi Wu, Shanker Kalyana-Sundaram, Xuhong Cao, Robert J Lonigro, Yun-Shao Sung, Chun-Liang Chen, Lei Zhang, Rui Wang, Fengyun Su and 11 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Nature genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03840772 (ERibulin in Advanced Solitary Fibrous Tumor, an ItaliaN Sarcoma Group Phase II Study), which is not on this map. Cited by 341 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
341citing papers in PubMed, 3 pooled it
48.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03840772 phase2completednot on this mapstarted 2019, after this paper: background citation

ERibulin in Advanced Solitary Fibrous Tumor, an ItaliaN Sarcoma Group Phase II Study (ERASING)

TypeinterventionalSponsorItalian Sarcoma GroupRan2019 to 2024Enrolled16ConditionsSolitary Fibrous TumorArmsEribulin
3 · Its place in the literature

Who cites it

341 citing papers in PubMed, 3 syntheses or guidelines pooled it, 810 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Lumbosacral spinal solitary fibrous tumors: compartment-specific surgical considerations and recurrence patterns in 60 systematically reviewed cases.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Systemic Therapy for Solitary Fibrous Tumor.Current treatment options in oncology · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Haemangiopericytoma and solitary fibrous tumour of the parotid gland: a scoping review.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2026
    Review

281 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 2 countries.

Dan R RobinsonMichigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Yi-Mi Wu
Shanker Kalyana-Sundaram
Xuhong Cao
Robert J Lonigro
Yun-Shao Sung
Chun-Liang Chen
Lei Zhang
Rui Wang
Fengyun Su
Matthew K Iyer
Sameek Roychowdhury
Javed Siddiqui
Kenneth J Pienta
Lakshmi P Kunju
Moshe Talpaz
Juan Miguel Mosquera
Samuel Singer
Scott M Schuetze
Cristina R Antonescu
Arul M Chinnaiyan
University of Michigan–Ann Arbor · USMichigan Center for Translational Pathology · USMemorial Sloan Kettering Cancer Center · USBharathidasan University · INCornell University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
VACCINIA PSA FOR ANDROGEN-MODULATED POST-SURGICAL RECURRENCE OF PROSTATE CANCERP50CA069568 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COONEY, KATHLEEN A · 1995 to 2013
$31.3M
SOFT TISSUE SARCOMA PROGRAM PROJECTP01CA047179 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI LADANYI, MARC · 1989 to 2010
$17.3M
SPORE in Soft Tissue SarcomaP50CA140146 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SPRIGGS, DAVID R · 2010 to 2014
$11.1M
Epitomic Biomarkers of Prostate CancerU01CA111275 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, RUBIN, MARK A. · 2004 to 2015
$6.8M
Howard Hughes Medical InstituteNCI NIH HHS 5 P30 CA46592NCI NIH HHS P01 CA047179NCI NIH HHS P01 CA047179-15A2NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA069568NCI NIH HHS P50 CA140146NCI NIH HHS P50 CA 140146-01NCI NIH HHS U01 CA111275
6 · The paper itself

Abstract

A 44-year old woman with recurrent solitary fibrous tumor (SFT)/hemangiopericytoma was enrolled in a clinical sequencing program including whole-exome and transcriptome sequencing. A gene fusion of the transcriptional repressor NAB2 with the transcriptional activator STAT6 was detected. Transcriptome sequencing of 27 additional SFTs identified the presence of a NAB2-STAT6 gene fusion in all tumors. Using RT-PCR and sequencing, we detected this fusion in all 51 SFTs, indicating high levels of recurrence. Expression of NAB2-STAT6 fusion proteins was confirmed in SFT, and the predicted fusion products harbor the early growth response (EGR)-binding domain of NAB2 fused to the activation domain of STAT6. Overexpression of the NAB2-STAT6 gene fusion induced proliferation in cultured cells and activated the expression of EGR-responsive genes. These studies establish NAB2-STAT6 as the defining driver mutation of SFT and provide an example of how neoplasia can be initiated by converting a transcriptional repressor of mitogenic pathways into a transcriptional activator.

Indexed as

AdultBase SequenceCell ProliferationCells, CulturedChromatin ImmunoprecipitationDNA Mutational AnalysisExomeFemaleFluorescent Antibody TechniqueGene Expression Regulation, NeoplasticGene FusionHigh-Throughput Nucleotide SequencingHumansImmunoblottingLuciferasesModels, GeneticLuciferasesNAB2 protein, humanRepressor ProteinsSTAT6 protein, humanSTAT6 Transcription Factor

Identifiers

PMID23313952
PMCPMC3654808
OpenAlexW1995826067

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.